Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer

MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 8; no. 10; p. e3071
Main Authors Wang, Wenrui, Zhang, Lingyu, Wang, Yangyang, Ding, Yongxing, Chen, Tiantian, Wang, Yueyue, Wang, Haifeng, Li, Yu, Duan, Kecai, Chen, Sulian, Yang, Qingling, Chen, Changjie
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 05.10.2017
Springer Nature B.V
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of β -catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model in vivo showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment.
AbstractList Abstract MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of β -catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model in vivo showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment.
MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of β-catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model in vivo showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment.
MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of β -catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model in vivo showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment.
Author Wang, Yangyang
Li, Yu
Duan, Kecai
Zhang, Lingyu
Chen, Sulian
Ding, Yongxing
Chen, Changjie
Yang, Qingling
Wang, Wenrui
Chen, Tiantian
Wang, Yueyue
Wang, Haifeng
Author_xml – sequence: 1
  givenname: Wenrui
  surname: Wang
  fullname: Wang, Wenrui
  organization: Department of Biotechnology, Bengbu Medical College
– sequence: 2
  givenname: Lingyu
  surname: Zhang
  fullname: Zhang, Lingyu
  organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College
– sequence: 3
  givenname: Yangyang
  surname: Wang
  fullname: Wang, Yangyang
  organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College, Clinical Laboratory, The First People’s Hospital of Changzhou
– sequence: 4
  givenname: Yongxing
  surname: Ding
  fullname: Ding, Yongxing
  organization: Department of Oncology, Bengbu Central Hospital
– sequence: 5
  givenname: Tiantian
  surname: Chen
  fullname: Chen, Tiantian
  organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College
– sequence: 6
  givenname: Yueyue
  surname: Wang
  fullname: Wang, Yueyue
  organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College
– sequence: 7
  givenname: Haifeng
  surname: Wang
  fullname: Wang, Haifeng
  organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College
– sequence: 8
  givenname: Yu
  surname: Li
  fullname: Li, Yu
  organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College
– sequence: 9
  givenname: Kecai
  surname: Duan
  fullname: Duan, Kecai
  organization: Department of Oncology, Bengbu Central Hospital
– sequence: 10
  givenname: Sulian
  surname: Chen
  fullname: Chen, Sulian
  organization: Department of Biochemistry and Molecular Biology, Bengbu Medical College
– sequence: 11
  givenname: Qingling
  surname: Yang
  fullname: Yang, Qingling
  email: yqlmimi@163.com
  organization: Department of Biochemistry and Molecular Biology, Bengbu Medical College
– sequence: 12
  givenname: Changjie
  surname: Chen
  fullname: Chen, Changjie
  email: tochenchangjie@163.com
  organization: Department of Biochemistry and Molecular Biology, Bengbu Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28981108$$D View this record in MEDLINE/PubMed
BookMark eNptkc9LHDEcxYNY_H31WAK9eJk1yWQymUtBxKogFEpF9BIymW_WyEyyJjOL_vfNula20lwSeJ_v--bx9tG2Dx4QOqZkRkkpT03XuTRjhNYzLsgW2mOE04JL2WxvvHfRUUpPJJ-yJKwSO2iXyUZSSuQeurv2y9AvYQA_4mDx4H4VvKLYeRwhuTRqbwCPAS-06d2oX6DH7WvW5lOvR-fn-P7u6uxhxbcRdBqxWU3EQ_TF6j7B0ft9gG5_XPw-vypufl5en5_dFKZifCxaZk1TGlkzK7quaw2xrBGVtbzW0gIpdSNAt0QYWoKuuaxtazSwUhChCe3KA_R97buY2gE6k2NE3atFdIOOrypop_5VvHtU87BUlZCkkiwbnLwbxPA8QRrV4JKBvtcewpQUbXgtGBGUZvTbJ_QpTNHneG8U4ZIzmanZmjIxpBTBfnyGErWqTb3Vpla1qVxbHvi6GeED_1tSBk7XQMqSn0Pc2Pt_yz8nK6Xt
CitedBy_id crossref_primary_10_1002_jbt_23613
crossref_primary_10_1016_j_talanta_2024_125777
crossref_primary_10_3390_ijms22116121
crossref_primary_10_1039_C7RA09042K
crossref_primary_10_1016_j_prp_2023_154701
crossref_primary_10_3389_fmicb_2019_01659
crossref_primary_10_1007_s13258_020_01028_1
crossref_primary_10_1186_s12935_021_01885_0
crossref_primary_10_1016_j_prp_2021_153405
crossref_primary_10_1007_s11033_021_07010_8
crossref_primary_10_3389_fbioe_2021_762489
crossref_primary_10_3390_molecules23071578
crossref_primary_10_1245_s10434_024_15592_3
crossref_primary_10_1002_jcp_27445
crossref_primary_10_1038_s10038_018_0510_3
crossref_primary_10_3390_ncrna6030029
crossref_primary_10_3389_fonc_2022_848286
crossref_primary_10_1007_s12094_023_03189_3
crossref_primary_10_17650_1994_4098_2022_18_3_52_63
crossref_primary_10_21886_2308_6424_2022_10_4_98_108
crossref_primary_10_1080_15476286_2020_1851540
crossref_primary_10_1096_fj_202100294RR
crossref_primary_10_1016_j_bcp_2021_114409
crossref_primary_10_1111_cpr_12648
crossref_primary_10_3390_ijms19041191
crossref_primary_10_1016_j_microc_2023_109260
crossref_primary_10_32604_oncologie_2022_022121
crossref_primary_10_1021_acs_jafc_0c07164
crossref_primary_10_1016_j_yexcr_2019_03_033
crossref_primary_10_1186_s40364_022_00361_9
crossref_primary_10_3390_ijms241612694
crossref_primary_10_1016_j_lfs_2020_117417
crossref_primary_10_19161_etd_1360783
crossref_primary_10_1016_j_ejphar_2020_173660
crossref_primary_10_2217_fon_2018_0741
crossref_primary_10_1007_s10911_021_09478_3
crossref_primary_10_1007_s11357_024_01260_7
crossref_primary_10_1002_jcp_29755
crossref_primary_10_1038_s41388_024_02959_9
crossref_primary_10_1038_s41419_018_0434_z
crossref_primary_10_3390_cancers12092698
crossref_primary_10_1016_j_prp_2018_12_026
crossref_primary_10_1080_15384047_2018_1529091
crossref_primary_10_1177_1933719119862050
crossref_primary_10_3389_fonc_2021_634596
crossref_primary_10_2174_1389557520999201214234421
crossref_primary_10_1007_s12282_022_01359_9
crossref_primary_10_1016_j_omto_2021_08_001
crossref_primary_10_1111_1759_7714_14928
crossref_primary_10_1016_j_biopha_2020_111172
crossref_primary_10_1016_j_crphar_2022_100131
crossref_primary_10_3390_diagnostics11010107
crossref_primary_10_1002_jgm_3168
crossref_primary_10_1002_tox_22938
crossref_primary_10_1016_j_radmp_2024_02_005
crossref_primary_10_3390_ijms21175950
crossref_primary_10_1002_jcb_27915
crossref_primary_10_1186_s13148_018_0587_8
crossref_primary_10_1155_2020_9512793
crossref_primary_10_3390_ncrna5010025
crossref_primary_10_1002_jcp_30751
crossref_primary_10_1186_s12935_018_0709_6
crossref_primary_10_3389_fonc_2021_768949
crossref_primary_10_3389_fgene_2020_627459
crossref_primary_10_1016_j_gene_2019_02_066
crossref_primary_10_1186_s12885_021_09010_0
crossref_primary_10_20517_cdr_2023_19
crossref_primary_10_3390_ani10101891
crossref_primary_10_1016_j_yexcr_2021_112518
crossref_primary_10_1016_j_bcp_2019_07_014
crossref_primary_10_18632_aging_203315
crossref_primary_10_2147_CMAR_S253152
crossref_primary_10_1007_s10620_020_06705_5
crossref_primary_10_1002_jcp_28888
crossref_primary_10_1016_j_cancergen_2020_08_005
crossref_primary_10_1039_C8MD00187A
crossref_primary_10_1089_dna_2020_6320
crossref_primary_10_1089_cbr_2020_3957
crossref_primary_10_2147_OTT_S282485
crossref_primary_10_3892_etm_2023_12173
Cites_doi 10.1038/onc.2011.223
10.1002/stem.741
10.1002/wrna.1229
10.1158/0008-5472.CAN-07-6247
10.3727/096504016X14685034103798
10.1371/journal.pone.0073004
10.3892/or_00000963
10.3892/or.2014.3296
10.1016/j.addr.2015.05.001
10.1158/0008-5472.CAN-08-2765
10.1158/1535-7163.MCT-11-0548
10.1007/s13277-016-5219-3
10.1186/s12935-016-0290-9
10.1158/2159-8290.CD-13-0159
10.1038/nrg1379
10.1158/1541-7786.MCR-12-0189
10.18632/oncotarget.3065
10.1016/j.cellsig.2013.11.032
10.1016/j.brainres.2010.08.074
10.1158/1078-0432.CCR-08-1818
10.1186/s13058-015-0526-y
10.1038/cddis.2016.361
10.1158/1535-7163.MCT-08-0021
10.1038/srep37421
10.18632/oncotarget.5495
10.1038/bjc.2014.136
10.1038/cddis.2017.178
10.1074/jbc.M114.620252
10.1186/1756-9966-30-20
10.1590/1414-431X20133324
10.1038/srep17618
10.1016/j.canlet.2011.07.026
10.1016/j.biopha.2015.12.018
10.1186/s13058-014-0446-2
10.1038/cdd.2014.112
10.1158/0008-5472.CAN-05-1783
10.1111/j.1582-4934.2008.00510.x
10.33549/physiolres.932289
10.1083/jcb.200709091
10.7314/APJCP.2013.14.6.3631
10.1172/JCI86573
10.1016/j.humpath.2011.08.013
10.1158/2159-8290.CD-15-0893
ContentType Journal Article
Copyright The Author(s) 2017
Copyright Nature Publishing Group Oct 2017
Copyright © 2017 The Author(s) 2017 The Author(s)
Copyright_xml – notice: The Author(s) 2017
– notice: Copyright Nature Publishing Group Oct 2017
– notice: Copyright © 2017 The Author(s) 2017 The Author(s)
DBID C6C
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/cddis.2017.460
DatabaseName Springer Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Science Database
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
Publicly Available Content Database


MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Open Access
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Involvement of miR-451 in resistance to paclitaxel
EISSN 2041-4889
EndPage e3071
ExternalDocumentID 10_1038_cddis_2017_460
28981108
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABAWZ
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
DIK
DWQXO
E3Z
EBLON
EBS
EJD
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
IPNFZ
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RIG
RNT
RPM
SNYQT
TR2
UKHRP
W2D
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c524t-b2fc93c872f6dddbc0f2965ff47a8fe03a96eab06c13ea7487fbcae23606a01d3
IEDL.DBID RPM
ISSN 2041-4889
IngestDate Tue Sep 17 21:13:34 EDT 2024
Fri Oct 25 21:48:45 EDT 2024
Thu Oct 10 17:11:27 EDT 2024
Fri Aug 23 01:18:58 EDT 2024
Wed Oct 16 00:59:50 EDT 2024
Fri Oct 11 20:48:54 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c524t-b2fc93c872f6dddbc0f2965ff47a8fe03a96eab06c13ea7487fbcae23606a01d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680582/
PMID 28981108
PQID 1947048428
PQPubID 2041963
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5680582
proquest_miscellaneous_1947620611
proquest_journals_1947048428
crossref_primary_10_1038_cddis_2017_460
pubmed_primary_28981108
springer_journals_10_1038_cddis_2017_460
PublicationCentury 2000
PublicationDate 2017-10-05
PublicationDateYYYYMMDD 2017-10-05
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-05
  day: 05
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2017
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Hammond (CR31) 2015; 87
Bergamaschi, Katzenellenbogen (CR34) 2012; 31
Singh, Gu, Agarwal (CR46) 2008; 68
Mao, Zhang, Deng, Mo, Yu, Lu (CR35) 2015; 5
Hong, Liang, Rehaman, Wang, Zhou, Zhou (CR8) 2016; 18
Sachdeva, Mito, Lee, Zhang, Li, Dodd (CR29) 2016; 126
Li, Mofunanya, Harris, Takemaru (CR32) 2008; 181
Schooneveld, Wildiers, Vergote, Vermeulen, Dirix, Van Laere (CR1) 2015; 17
Wilczynska, Bushell (CR30) 2015; 22
Fang, Feng, Wu, Srinivas, Yang, Fa (CR43) 2013; 8
Zhang, Geng, Talmon, Wang (CR12) 2015; 290
Zhu, Zou, Nie, Kou, Wu, Wang (CR15) 2016; 7
Bian, Pan, Yang, Wang, De (CR28) 2011; 30
Nishimura, Jung, Shah, Lu, Spizzo, Shimizu (CR38) 2013; 3
Guo, Xiao, Sun, Liu (CR42) 2012; 61
Kovalchuk, Filkowski, Meservy, Ilnytskyy, Tryndyak, Chekhun (CR27) 2008; 7
Zhang, Liu, Feng, Mao, Zhang, Lu (CR10) 2016; 77
Li, Zhang, Cai, Bian (CR23) 2013; 29
Bitarte, Bandres, Boni, Zarate, Rodriguez, Gonzalez-Huarriz (CR18) 2011; 29
Rizvi, Truong, Truong (CR2) 2017; 9
Xu, Hu, Shen, Shen (CR5) 2016; 16
Wang, Tian, Jiang, Wang, Li, She (CR17) 2011; 311
Shah, Calin (CR37) 2014; 5
Zhang, Gill, Issacs, Atmore, Johns, Delbridge (CR41) 2012; 43
Neal, Yao, Yang, Zhou, Nguyen, Lu (CR33) 2009; 69
De Mattos-Arruda, Bottai, Nuciforo, Di Tommaso, Giovannetti, Peg (CR14) 2015; 6
Wang, Zhan, Xu, Chen, Long, Shi (CR13) 2017; 8
Wang, Chen, Meng, Jing, Lu, Yang (CR44) 2015; 5
Rupaimoole, Calin, Lopez-Berestein, Sood (CR22) 2016; 6
He, Hannon (CR6) 2004; 5
Iorio, Ferracin, Liu, Veronese, Spizzo, Sabbioni (CR7) 2005; 65
Fang, Shen, Cao, Li, Qin, Chen (CR36) 2014; 47
Bandres, Bitarte, Arias, Agorreta, Fortes, Agirre (CR26) 2009; 15
Krausova, Korinek (CR40) 2014; 26
Chen, Chuang, Yang, Liao, Yu, Chen (CR21) 2012; 10
Howell, Anderson, Clarke, Duffy, Evans, Closas (CR3) 2014; 16
Zhang, Kim, Jin, Pfent, Cao, Amendt (CR11) 2012; 11
Lv, Hu, Tie, Du, Fu, Gao (CR25) 2014; 32
Guo, Nan, Zhen, Zhang, Guo, Kai (CR19) 2016; 37
Wang, Song, Shen, Sun, Qu, Shang (CR20) 2017; 25
Wang, Lee (CR9) 2009; 13
Su, Zhang, Shi, Ma, Pu, Wang (CR39) 2012; 40
Yang, Wang, Lu, Zhao, Zhu, Chen (CR16) 2015; 6
Hassan, Ansari, Spooner, Hussain (CR4) 2010; 24
Yang, Huang, Wu, Cai, Zhu, Lu (CR45) 2014; 110
Nan, Han, Zhang, Wang, Jia, Yang (CR24) 2010; 1359
24642627 - Br J Cancer. 2014 Apr 15;110(8):1958-67
22034498 - Mol Cancer Ther. 2012 Jan;11(1):108-18
24308963 - Cell Signal. 2014 Mar;26(3):570-9
23886157 - Asian Pac J Cancer Prev. 2013;14(6):3631-4
20878101 - Oncol Rep. 2010 Nov;24(5):1121-31
22211245 - Int J Oncol. 2012 Apr;40(4):1162-70
18645025 - Mol Cancer Ther. 2008 Jul;7(7):2152-9
19318487 - Clin Cancer Res. 2009 Apr 1;15(7):2281-90
22670697 - Physiol Res. 2012;61(4):337-46
21329503 - J Exp Clin Cancer Res. 2011 Feb 17;30:20
20816946 - Brain Res. 2010 Nov 4;1359:14-21
16103053 - Cancer Res. 2005 Aug 15;65(16):7065-70
15211354 - Nat Rev Genet. 2004 Jul;5(7):522-31
26620926 - Sci Rep. 2015 Dec 01;5:17618
25616665 - J Biol Chem. 2015 Mar 6;290(10):6215-25
25849621 - Breast Cancer Res. 2015 Feb 18;17:21
27476171 - Tumour Biol. 2016 Oct;37(10 ):13751-13761
26865249 - Cancer Discov. 2016 Mar;6(3):235-46
26796277 - Biomed Pharmacother. 2016 Feb;77:135-41
27857177 - Sci Rep. 2016 Nov 18;6:37421
22204713 - Hum Pathol. 2012 Jul;43(7):1044-50
27035817 - J Clin Invest. 2016 Apr 1;126(4):1606
24968707 - Oncol Rep. 2014 Sep;32(3):1021-8
18573912 - J Cell Biol. 2008 Jun 30;181(7):1141-54
21875770 - Cancer Lett. 2011 Dec 8;311(2):203-9
27809310 - Cell Death Dis. 2016 Nov 3;7(11):e2454
25979468 - Adv Drug Deliv Rev. 2015 Jun 29;87:3-14
26900348 - Cancer Cell Int. 2016 Feb 20;16:13
24687772 - Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):537-48
25605244 - Oncotarget. 2015 Feb 20;6(5):3268-79
21666713 - Oncogene. 2012 Jan 5;31(1):39-47
24002999 - Cancer Discov. 2013 Nov;3(11):1302-15
22912335 - Mol Cancer Res. 2012 Oct;10(10):1319-31
26452030 - Oncotarget. 2015 Nov 10;6(35):37269-80
28081727 - Oncol Res. 2017 Jan 2;25(1):1-10
19318578 - Cancer Res. 2009 Apr 15;69(8):3425-32
28492560 - Cell Death Dis. 2017 May 11;8(5):e2770
18339887 - Cancer Res. 2008 Mar 15;68(6):2043-50
25190144 - Cell Death Differ. 2015 Jan;22(1):22-33
19175697 - J Cell Mol Med. 2009 Jan;13(1):12-23
26269755 - Am J Cancer Res. 2015 May 15;5(6):1939-53
25467785 - Breast Cancer Res. 2014 Sep 28;16(5):446
28706762 - Cureus. 2017 Jun 11;9(6):e1337
21948564 - Stem Cells. 2011 Nov;29(11):1661-71
24519092 - Braz J Med Biol Res. 2014 Jan;47(1):60-9
24015284 - PLoS One. 2013 Aug 27;8(8):e73004
QL Yang (BFcddis2017460_CR16) 2015; 6
MY Shah (BFcddis2017460_CR37) 2014; 5
FQ Li (BFcddis2017460_CR32) 2008; 181
CL Neal (BFcddis2017460_CR33) 2009; 69
S Zhang (BFcddis2017460_CR11) 2012; 11
XY Wang (BFcddis2017460_CR44) 2015; 5
MS Hassan (BFcddis2017460_CR4) 2010; 24
HB Guo (BFcddis2017460_CR19) 2016; 37
Y Guo (BFcddis2017460_CR42) 2012; 61
Y Wang (BFcddis2017460_CR9) 2009; 13
O Kovalchuk (BFcddis2017460_CR27) 2008; 7
HB Bian (BFcddis2017460_CR28) 2011; 30
A Howell (BFcddis2017460_CR3) 2014; 16
H Wang (BFcddis2017460_CR13) 2017; 8
R Rupaimoole (BFcddis2017460_CR22) 2016; 6
HY Li (BFcddis2017460_CR23) 2013; 29
G Lv (BFcddis2017460_CR25) 2014; 32
J Zhang (BFcddis2017460_CR41) 2012; 43
Y Fang (BFcddis2017460_CR43) 2013; 8
J Su (BFcddis2017460_CR39) 2012; 40
A Bergamaschi (BFcddis2017460_CR34) 2012; 31
Y Fang (BFcddis2017460_CR36) 2014; 47
L De Mattos-Arruda (BFcddis2017460_CR14) 2015; 6
M Sachdeva (BFcddis2017460_CR29) 2016; 126
JH Xu (BFcddis2017460_CR5) 2016; 16
Y Zhang (BFcddis2017460_CR12) 2015; 290
YT Hong (BFcddis2017460_CR8) 2016; 18
J Zhang (BFcddis2017460_CR10) 2016; 77
EV Schooneveld (BFcddis2017460_CR1) 2015; 17
Y Nan (BFcddis2017460_CR24) 2010; 1359
QL Yang (BFcddis2017460_CR45) 2014; 110
E Bandres (BFcddis2017460_CR26) 2009; 15
MV Iorio (BFcddis2017460_CR7) 2005; 65
M Nishimura (BFcddis2017460_CR38) 2013; 3
XC Wang (BFcddis2017460_CR17) 2011; 311
N Bitarte (BFcddis2017460_CR18) 2011; 29
CH Chen (BFcddis2017460_CR21) 2012; 10
J Wang (BFcddis2017460_CR20) 2017; 25
SM Hammond (BFcddis2017460_CR31) 2015; 87
A Wilczynska (BFcddis2017460_CR30) 2015; 22
M Krausova (BFcddis2017460_CR40) 2014; 26
LY Mao (BFcddis2017460_CR35) 2015; 5
RP Singh (BFcddis2017460_CR46) 2008; 68
W Rizvi (BFcddis2017460_CR2) 2017; 9
J Zhu (BFcddis2017460_CR15) 2016; 7
L He (BFcddis2017460_CR6) 2004; 5
References_xml – volume: 32
  start-page: 1021
  year: 2014
  end-page: 1028
  ident: CR25
  article-title: MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration
  publication-title: Oncol Rep
  contributor:
    fullname: Gao
– volume: 9
  start-page: e1337
  year: 2017
  ident: CR2
  article-title: Metastatic breast cancer with BRCA mutation discovered by next-generation sequencing responding to olaparib
  publication-title: Cureus
  contributor:
    fullname: Truong
– volume: 290
  start-page: 6215
  year: 2015
  end-page: 6225
  ident: CR12
  article-title: MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer
  publication-title: J Biol Chem
  contributor:
    fullname: Wang
– volume: 311
  start-page: 203
  year: 2011
  end-page: 220
  ident: CR17
  article-title: The expression and function of miRNA-451 in non-small cell lung cancer
  publication-title: Cancer Lett
  contributor:
    fullname: She
– volume: 31
  start-page: 39
  year: 2012
  end-page: 47
  ident: CR34
  article-title: Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
  publication-title: Oncogene
  contributor:
    fullname: Katzenellenbogen
– volume: 6
  start-page: 37269
  year: 2015
  end-page: 37280
  ident: CR14
  article-title: MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
  publication-title: Oncotarget
  contributor:
    fullname: Peg
– volume: 29
  start-page: 1661
  year: 2011
  end-page: 1671
  ident: CR18
  article-title: MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells
  publication-title: Stem Cells
  contributor:
    fullname: Gonzalez-Huarriz
– volume: 26
  start-page: 570
  year: 2014
  end-page: 579
  ident: CR40
  article-title: Wnt signaling in adult intestinal stem cells and cancer
  publication-title: Cell Signal
  contributor:
    fullname: Korinek
– volume: 16
  start-page: 13
  year: 2016
  ident: CR5
  article-title: Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
  publication-title: Cancer Cell Int
  contributor:
    fullname: Shen
– volume: 15
  start-page: 2281
  year: 2009
  end-page: 2290
  ident: CR26
  article-title: MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells
  publication-title: Clin Cancer Res
  contributor:
    fullname: Agirre
– volume: 65
  start-page: 7065
  year: 2005
  end-page: 7070
  ident: CR7
  article-title: MicroRNA gene expression deregulation in human breast cancer
  publication-title: Cancer Res
  contributor:
    fullname: Sabbioni
– volume: 87
  start-page: 3
  year: 2015
  end-page: 14
  ident: CR31
  article-title: An overview of microRNAs
  publication-title: Adv Drug Deliv Rev.
  contributor:
    fullname: Hammond
– volume: 181
  start-page: 1141
  year: 2008
  end-page: 1154
  ident: CR32
  article-title: Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity
  publication-title: J Cell Biol
  contributor:
    fullname: Takemaru
– volume: 13
  start-page: 12
  year: 2009
  end-page: 23
  ident: CR9
  article-title: MicroRNA and cancer–focus on apoptosis
  publication-title: J Cell Mol Med
  contributor:
    fullname: Lee
– volume: 22
  start-page: 22
  year: 2015
  end-page: 33
  ident: CR30
  article-title: The complexity of miRNA-mediated repression
  publication-title: Cell Death Differ
  contributor:
    fullname: Bushell
– volume: 25
  start-page: 1
  year: 2017
  end-page: 10
  ident: CR20
  article-title: MicroRNA-200a suppresses cell invasion and migration by directly targeting GAB1 in hepatocellular carcinoma
  publication-title: Oncol Res
  contributor:
    fullname: Shang
– volume: 8
  start-page: e2770
  year: 2017
  ident: CR13
  article-title: miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer
  publication-title: Cell Death Dis
  contributor:
    fullname: Shi
– volume: 17
  start-page: 21
  year: 2015
  ident: CR1
  article-title: Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
  publication-title: Breast Cancer Res
  contributor:
    fullname: Van Laere
– volume: 47
  start-page: 60
  year: 2014
  end-page: 69
  ident: CR36
  article-title: Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
  publication-title: Braz J Med Biol Res
  contributor:
    fullname: Chen
– volume: 5
  start-page: 17618
  year: 2015
  ident: CR44
  article-title: MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
  publication-title: Sci Rep
  contributor:
    fullname: Yang
– volume: 11
  start-page: 108
  year: 2012
  end-page: 118
  ident: CR11
  article-title: Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells
  publication-title: Mol Cancer Ther
  contributor:
    fullname: Amendt
– volume: 40
  start-page: 1162
  year: 2012
  end-page: 1170
  ident: CR39
  article-title: MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin
  publication-title: Int J Oncol
  contributor:
    fullname: Wang
– volume: 6
  start-page: 3268
  year: 2015
  end-page: 3279
  ident: CR16
  article-title: MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
  publication-title: Oncotarget
  contributor:
    fullname: Chen
– volume: 5
  start-page: 537
  year: 2014
  end-page: 548
  ident: CR37
  article-title: MicroRNAs as therapeutic targets in human cancers
  publication-title: Wiley Interdiscip Rev RNA
  contributor:
    fullname: Calin
– volume: 69
  start-page: 3425
  year: 2009
  end-page: 3432
  ident: CR33
  article-title: 14-3-3ζ overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival
  publication-title: Cancer Res
  contributor:
    fullname: Lu
– volume: 24
  start-page: 1121
  year: 2010
  end-page: 1131
  ident: CR4
  article-title: Chemotherapy for breast cancer (review)
  publication-title: Oncol Rep
  contributor:
    fullname: Hussain
– volume: 37
  start-page: 13751
  year: 2016
  end-page: 13761
  ident: CR19
  article-title: MiRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1
  publication-title: Tumour Biol
  contributor:
    fullname: Kai
– volume: 68
  start-page: 2043
  year: 2008
  end-page: 2050
  ident: CR46
  article-title: Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis
  publication-title: Cancer Res
  contributor:
    fullname: Agarwal
– volume: 6
  start-page: 235
  year: 2016
  end-page: 246
  ident: CR22
  article-title: MicroRNA deregulation in cancer cells and the tumor microenvironment
  publication-title: Cancer Discov
  contributor:
    fullname: Sood
– volume: 43
  start-page: 1044
  year: 2012
  end-page: 1050
  ident: CR41
  article-title: The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer
  publication-title: Hum Pathol
  contributor:
    fullname: Delbridge
– volume: 29
  start-page: 3631
  year: 2013
  end-page: 3634
  ident: CR23
  article-title: MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway
  publication-title: Asian Pac J Cancer Prev
  contributor:
    fullname: Bian
– volume: 126
  start-page: 1606
  year: 2016
  ident: CR29
  article-title: MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes
  publication-title: J Clin Invest
  contributor:
    fullname: Dodd
– volume: 16
  start-page: 446
  year: 2014
  ident: CR3
  article-title: Risk determination and prevention of breast cancer
  publication-title: Breast Cancer Res.
  contributor:
    fullname: Closas
– volume: 77
  start-page: 135
  year: 2016
  end-page: 141
  ident: CR10
  article-title: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin
  publication-title: Biomed Pharmacother
  contributor:
    fullname: Lu
– volume: 5
  start-page: 522
  year: 2004
  end-page: 531
  ident: CR6
  article-title: MicroRNAs: small RNAs with a big role in gene regulation
  publication-title: Nat Rev Genet
  contributor:
    fullname: Hannon
– volume: 5
  start-page: 1939
  year: 2015
  end-page: 1953
  ident: CR35
  article-title: Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer
  publication-title: Am J Cancer Res
  contributor:
    fullname: Lu
– volume: 7
  start-page: e2454
  year: 2016
  ident: CR15
  article-title: Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression
  publication-title: Cell Death Dis
  contributor:
    fullname: Wang
– volume: 10
  start-page: 1319
  year: 2012
  end-page: 1331
  ident: CR21
  article-title: A novel function of YWHAZ/β-catenin axis in promoting epithelial–mesenchymal transition and lung cancer metastasis
  publication-title: Mol Cancer Res
  contributor:
    fullname: Chen
– volume: 30
  start-page: 20
  year: 2011
  ident: CR28
  article-title: Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
  publication-title: J Exp Clin Cancer Res
  contributor:
    fullname: De
– volume: 7
  start-page: 2152
  year: 2008
  end-page: 2159
  ident: CR27
  article-title: Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
  publication-title: Mol Cancer Ther
  contributor:
    fullname: Chekhun
– volume: 8
  start-page: e73004
  year: 2013
  ident: CR43
  article-title: Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a
  publication-title: PLoS ONE
  contributor:
    fullname: Fa
– volume: 61
  start-page: 337
  year: 2012
  end-page: 346
  ident: CR42
  article-title: Wnt/β-catenin signaling: a promising new target for fibrosis diseases
  publication-title: Physiol Res
  contributor:
    fullname: Liu
– volume: 1359
  start-page: 14
  year: 2010
  end-page: 21
  ident: CR24
  article-title: MiRNA-451 plays a role as tumor suppressor in human glioma cells
  publication-title: Brain Res
  contributor:
    fullname: Yang
– volume: 110
  start-page: 1958
  year: 2014
  end-page: 1967
  ident: CR45
  article-title: Acquisition of epithelial mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
  publication-title: Br J Cancer
  contributor:
    fullname: Lu
– volume: 3
  start-page: 1302
  year: 2013
  end-page: 1315
  ident: CR38
  article-title: Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
  publication-title: Cancer Discov
  contributor:
    fullname: Shimizu
– volume: 18
  start-page: 37421
  year: 2016
  ident: CR8
  article-title: MiR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer
  publication-title: Sci Rep
  contributor:
    fullname: Zhou
– volume: 31
  start-page: 39
  year: 2012
  ident: BFcddis2017460_CR34
  publication-title: Oncogene
  doi: 10.1038/onc.2011.223
  contributor:
    fullname: A Bergamaschi
– volume: 29
  start-page: 1661
  year: 2011
  ident: BFcddis2017460_CR18
  publication-title: Stem Cells
  doi: 10.1002/stem.741
  contributor:
    fullname: N Bitarte
– volume: 5
  start-page: 537
  year: 2014
  ident: BFcddis2017460_CR37
  publication-title: Wiley Interdiscip Rev RNA
  doi: 10.1002/wrna.1229
  contributor:
    fullname: MY Shah
– volume: 68
  start-page: 2043
  year: 2008
  ident: BFcddis2017460_CR46
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6247
  contributor:
    fullname: RP Singh
– volume: 25
  start-page: 1
  year: 2017
  ident: BFcddis2017460_CR20
  publication-title: Oncol Res
  doi: 10.3727/096504016X14685034103798
  contributor:
    fullname: J Wang
– volume: 8
  start-page: e73004
  year: 2013
  ident: BFcddis2017460_CR43
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0073004
  contributor:
    fullname: Y Fang
– volume: 5
  start-page: 1939
  year: 2015
  ident: BFcddis2017460_CR35
  publication-title: Am J Cancer Res
  contributor:
    fullname: LY Mao
– volume: 40
  start-page: 1162
  year: 2012
  ident: BFcddis2017460_CR39
  publication-title: Int J Oncol
  contributor:
    fullname: J Su
– volume: 24
  start-page: 1121
  year: 2010
  ident: BFcddis2017460_CR4
  publication-title: Oncol Rep
  doi: 10.3892/or_00000963
  contributor:
    fullname: MS Hassan
– volume: 32
  start-page: 1021
  year: 2014
  ident: BFcddis2017460_CR25
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.3296
  contributor:
    fullname: G Lv
– volume: 9
  start-page: e1337
  year: 2017
  ident: BFcddis2017460_CR2
  publication-title: Cureus
  contributor:
    fullname: W Rizvi
– volume: 87
  start-page: 3
  year: 2015
  ident: BFcddis2017460_CR31
  publication-title: Adv Drug Deliv Rev.
  doi: 10.1016/j.addr.2015.05.001
  contributor:
    fullname: SM Hammond
– volume: 69
  start-page: 3425
  year: 2009
  ident: BFcddis2017460_CR33
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-2765
  contributor:
    fullname: CL Neal
– volume: 11
  start-page: 108
  year: 2012
  ident: BFcddis2017460_CR11
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-11-0548
  contributor:
    fullname: S Zhang
– volume: 37
  start-page: 13751
  year: 2016
  ident: BFcddis2017460_CR19
  publication-title: Tumour Biol
  doi: 10.1007/s13277-016-5219-3
  contributor:
    fullname: HB Guo
– volume: 16
  start-page: 13
  year: 2016
  ident: BFcddis2017460_CR5
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-016-0290-9
  contributor:
    fullname: JH Xu
– volume: 3
  start-page: 1302
  year: 2013
  ident: BFcddis2017460_CR38
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-13-0159
  contributor:
    fullname: M Nishimura
– volume: 5
  start-page: 522
  year: 2004
  ident: BFcddis2017460_CR6
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg1379
  contributor:
    fullname: L He
– volume: 10
  start-page: 1319
  year: 2012
  ident: BFcddis2017460_CR21
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-12-0189
  contributor:
    fullname: CH Chen
– volume: 6
  start-page: 3268
  year: 2015
  ident: BFcddis2017460_CR16
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3065
  contributor:
    fullname: QL Yang
– volume: 26
  start-page: 570
  year: 2014
  ident: BFcddis2017460_CR40
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2013.11.032
  contributor:
    fullname: M Krausova
– volume: 1359
  start-page: 14
  year: 2010
  ident: BFcddis2017460_CR24
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2010.08.074
  contributor:
    fullname: Y Nan
– volume: 15
  start-page: 2281
  year: 2009
  ident: BFcddis2017460_CR26
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-1818
  contributor:
    fullname: E Bandres
– volume: 17
  start-page: 21
  year: 2015
  ident: BFcddis2017460_CR1
  publication-title: Breast Cancer Res
  doi: 10.1186/s13058-015-0526-y
  contributor:
    fullname: EV Schooneveld
– volume: 7
  start-page: e2454
  year: 2016
  ident: BFcddis2017460_CR15
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2016.361
  contributor:
    fullname: J Zhu
– volume: 7
  start-page: 2152
  year: 2008
  ident: BFcddis2017460_CR27
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-08-0021
  contributor:
    fullname: O Kovalchuk
– volume: 18
  start-page: 37421
  year: 2016
  ident: BFcddis2017460_CR8
  publication-title: Sci Rep
  doi: 10.1038/srep37421
  contributor:
    fullname: YT Hong
– volume: 6
  start-page: 37269
  year: 2015
  ident: BFcddis2017460_CR14
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5495
  contributor:
    fullname: L De Mattos-Arruda
– volume: 110
  start-page: 1958
  year: 2014
  ident: BFcddis2017460_CR45
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2014.136
  contributor:
    fullname: QL Yang
– volume: 8
  start-page: e2770
  year: 2017
  ident: BFcddis2017460_CR13
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.178
  contributor:
    fullname: H Wang
– volume: 290
  start-page: 6215
  year: 2015
  ident: BFcddis2017460_CR12
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.620252
  contributor:
    fullname: Y Zhang
– volume: 30
  start-page: 20
  year: 2011
  ident: BFcddis2017460_CR28
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-30-20
  contributor:
    fullname: HB Bian
– volume: 47
  start-page: 60
  year: 2014
  ident: BFcddis2017460_CR36
  publication-title: Braz J Med Biol Res
  doi: 10.1590/1414-431X20133324
  contributor:
    fullname: Y Fang
– volume: 5
  start-page: 17618
  year: 2015
  ident: BFcddis2017460_CR44
  publication-title: Sci Rep
  doi: 10.1038/srep17618
  contributor:
    fullname: XY Wang
– volume: 311
  start-page: 203
  year: 2011
  ident: BFcddis2017460_CR17
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2011.07.026
  contributor:
    fullname: XC Wang
– volume: 77
  start-page: 135
  year: 2016
  ident: BFcddis2017460_CR10
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2015.12.018
  contributor:
    fullname: J Zhang
– volume: 16
  start-page: 446
  year: 2014
  ident: BFcddis2017460_CR3
  publication-title: Breast Cancer Res.
  doi: 10.1186/s13058-014-0446-2
  contributor:
    fullname: A Howell
– volume: 22
  start-page: 22
  year: 2015
  ident: BFcddis2017460_CR30
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2014.112
  contributor:
    fullname: A Wilczynska
– volume: 65
  start-page: 7065
  year: 2005
  ident: BFcddis2017460_CR7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-1783
  contributor:
    fullname: MV Iorio
– volume: 13
  start-page: 12
  year: 2009
  ident: BFcddis2017460_CR9
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2008.00510.x
  contributor:
    fullname: Y Wang
– volume: 61
  start-page: 337
  year: 2012
  ident: BFcddis2017460_CR42
  publication-title: Physiol Res
  doi: 10.33549/physiolres.932289
  contributor:
    fullname: Y Guo
– volume: 181
  start-page: 1141
  year: 2008
  ident: BFcddis2017460_CR32
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200709091
  contributor:
    fullname: FQ Li
– volume: 29
  start-page: 3631
  year: 2013
  ident: BFcddis2017460_CR23
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2013.14.6.3631
  contributor:
    fullname: HY Li
– volume: 126
  start-page: 1606
  year: 2016
  ident: BFcddis2017460_CR29
  publication-title: J Clin Invest
  doi: 10.1172/JCI86573
  contributor:
    fullname: M Sachdeva
– volume: 43
  start-page: 1044
  year: 2012
  ident: BFcddis2017460_CR41
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2011.08.013
  contributor:
    fullname: J Zhang
– volume: 6
  start-page: 235
  year: 2016
  ident: BFcddis2017460_CR22
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-15-0893
  contributor:
    fullname: R Rupaimoole
SSID ssj0000330256
Score 2.5095868
Snippet MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer....
Abstract MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e3071
SubjectTerms 14-3-3 Proteins - genetics
631/337/384/331
631/67/1059/2326
631/67/1059/602
692/699/67/1347
Animals
Antibodies
Apoptosis
Apoptosis - genetics
Biochemistry
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - genetics
Breast Neoplasms - pathology
c-Myc protein
Cell adhesion & migration
Cell Biology
Cell Culture
Cell migration
Cell Movement - genetics
Cell Proliferation - genetics
Cyclin D1
Drug resistance
Drug Resistance, Neoplasm - genetics
Ectopic expression
Female
Gene expression
Gene Expression Regulation, Neoplastic
Humans
Immunology
Life Sciences
MCF-7 Cells
Mice
MicroRNAs - genetics
miRNA
Molecular modelling
Monooxygenase
Myc protein
Original
original-article
Paclitaxel
Paclitaxel - administration & dosage
Paclitaxel - adverse effects
Post-transcription
siRNA
Transcription
Tumor cell lines
Xenograft Model Antitumor Assays
Xenografts
β-Catenin
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS98wED_cVwZ7GdO5rZuTCIP50tkmbdI-DSfKdwNFZKLbS0nShH1BW6cV5n-_u7T9-hNf-pIrae6uyX3uLncAn4zNJE98GZecXDcizWKTCnxwhweGUlqVdMF5b19Oj7IfJ_nJ4HC7HNIqxz0xbNR1a8lHvolgW6G2obX89fxvTF2jKLo6tNB4BosckUIygcVvO_sHh3MvS4JwHQ_1sVqjKDYtpelQSpf6koW6lLdOowcm5sNMyXvh0nAK7b6Cl4P5yLZ6eS_BgmuW4XnfUPL6NRx_b3C7CSXAO9Z6djY7jLM8ZbOGIawmUxFlzLqWIVKm6tz_3Ckz1zgWGtLjjOzX8XTrN9EbylbvmKU3LlbgaHfn5_Y0HlonxDbnWYes9rYUtlDcy7qujU08L2XufaZ04V0idCmdNom0qXBaIWrxxmrHBeIZnaS1eAOTpm3cO2AaLazaOI2mgc5ErQpqQWVdjVjIo3koI_g8srA67ytkVCGyLYoqMLsiZlfI7AhWRw5Xw59yWd3INYL1-TDqOAUudOPaq54GNUqmaQRve4HMp0LAWNBVhgjUHVHNCah-9t2RZvYn1NHOZZHkBY9gYxTqrc96dAXvn17BB3hBlCHXL1-FSXdx5T6izdKZtUEx_wO0z-3n
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwEB2hIiQuqOUz0CIjIcElJbEd2zmgqkJUCxIcEKsWLpHt2GKlkqVLKnX_fWeczcKy5ZJDPJaTmYk9L36eAXjpvFS8iHVec_p1I0qZu1LghQdcMLS2uqYDzp8-q8lUfjyrzv7wn1YK_H0jtKN6UtPF-eHVxfIIP_i3w5Fx88YT84ZYWvpQKoTvt7lElE40vlWon2ZlvIXL-5i3casbZQU2tSFW_OYStRV3btMn_9lDTUvTyS7cW8WU7Hhwgj24Fbr7cGeoMrl8AKcfOpyDUl7wns0j-zn7ksuqZLOOIdam-BENz_o5Q_hMKbuvwjlzS2xLVepxRPbtdHL8neQdUdh75qnH4iFMT95_fTfJV_UUcl9x2aP-o6-FN5pH1bat80XktapilNqaGAphaxWsK5QvRbAaoUx03gYuEOTYomzFI9jp5l14Asxi2NW6YDFesFK02lBdKh9aBEgRY0aVwatRhc2vIW1Gk7a7hWmS3hvSe4N6z2B_1HAzWr8pa6lxakFolMGLdTM6Pu1m2C7MLwcZdDNVlhk8HgyyHmq0ZAZ6w1RrAUqqvdnSzX6k5NqVMkVleAavR6P-9Vg3vsHT_w7_DO6SUOL-Vfuw0y8uwwHGML17npzzGoVA74E
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Open Access
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS-QwEB8O5eBeRL0P6xc5ELyX3rVNmqSPsriswt2DuOx6LyVJE1zwusdaQf97Z9rdxXV98KUUMiHNTJqZX2YyA3BinZBZEoq4yOjohqcitinHR-ZRYShlVEEXnH__kYOhuBzn43mALN2FWfHfc_3LUVQNRWCpn0IiNN9E_aspdKsne8uzlARBOaruRU7GtW6rOmfNkFyPh3zlFG11TX8btuZGIjvrpLoDH3y9Cx-7spFPn2F0UeOm0ib6btg0sH-Tq1jkKZvUDMEzGYQoSdZMGeJhysH96O-YfcK2tuw8jshuRoOzv0RvKSa9YY56zL7AsH9-3RvE8wIJscsz0SBDgyu40yoLsqoq65KQFTIPQSijg0-4KaQ3NpEu5d4oxCbBOuMzjqjFJGnFv8JGPa39HjCDdlRlvUEDwAheKU2FppyvEPEENAJlBKcLFpb_uzwYZeu_5rpsmV0Ss0tkdgSHCw6X8__hvkwLoXCvQKwTwfdlM65kck-Y2k8fOhpcNzJNI_jWCWQ5FMJCTRcWIlAroloSUJbs1ZZ6cttmy86lTnKdRfBjIdQXn_XmDPbfT3oAn-i1je7LD2GjmT34I7RSGnvcLtFny0TlIw
  priority: 102
  providerName: Springer Nature
Title Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
URI https://link.springer.com/article/10.1038/cddis.2017.460
https://www.ncbi.nlm.nih.gov/pubmed/28981108
https://www.proquest.com/docview/1947048428
https://search.proquest.com/docview/1947620611
https://pubmed.ncbi.nlm.nih.gov/PMC5680582
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_6wWAvZes-6q0zGgy6Fye2JUvyYxda0kK6Ulqa7cVIskQDjVM6F9b_fic5Ds26p70YjGRLvjtL95N-ugP4og3jeerKpMz90g3NWKIzipfc4oQhhBKlP-A8OePjK3Y6LaYbUPRnYQJp3-jZoLmdD5rZTeBW3s3NsOeJDc8no4LLtJD5cBM20UCfQPQw_CJCx3m8D9BI5dB4Zo5ncYkB4z71G4IM6env63PRMwfzOU_yr83SMAcdv4KdpfNIDrtOvoYN2-zCiy6d5OMbuD5pcLAJAcBbsnBkPrtIWJGRWUMQVHtHETVM2gVBnOxjc_-2t0Q_YllIR48tkh_X48Ofvr72XPWWGP_E_Vu4Oj66HI2TZeKExBQ5a1HQzpTUSJE7Xte1NqnLS144x4SSzqZUldwqnXKTUasEYhanjbI5RTSj0qym72CrWTR2D4hC_6rWVqFjoBithfQJqIytEQk5dA55BAe9CKu7Lj5GFfa1qayC3Csv9wrlHsF-L-Fq-Z_8qrKSCRxDEANF8HlVjBbuty1UYxcPXR20J55lEbzvFLJqqtdkBGJNVasKPnr2egkaVYiivTSiCL72Sn3SrX9-wYf_buQjvPQvCSTAYh-22vsH-wmdmVbHaMJTEcP2t6Oz8wu8G_FRHBYG8DphMvarht_jYOJ_AJHh-6s
link.rule.ids 230,315,730,783,787,867,888,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,41132,42201,43322,43817,51588,53804,53806,74079,74636
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT90wDLc2pmlcEGMMCmwLEtJ2KbRNm7QnhNDQY3wcEIgHlypJE_Ek1jIo0vjvZ6ftA8a0Sy9JlNZ2Y_9sxwbY0CYVSeSKsEjIdcPjNNQxx0diUWFIqWRBF5yPjsXoLP0xzsa9w-2uT6sczkR_UFeNIR_5FoJtidKG1vL2za-QukZRdLVvofEa3lAdLupgIMdy6mOJEKyjSh9qNfJ8y1CSDiV0yc3UV6V8ooteGJgv8yT_CpZ6HbQ3D3O98ch2Om6_h1e2XoC3XTvJhw9wvl_jYeMLgLescezn5CRMs5hNaoagmgxF5DBrG4Y4mWpz_7bXTD_gmG9Hjzuyi_PRziXN15Sr3jJDK24X4Wzv--nuKOwbJ4QmS9IWCe1MwU0uEyeqqtImckkhMudSqXJnI64KYZWOhIm5VRIxi9NG2YQjmlFRXPGPMFM3tV0GptC-qrRVaBiolFcypwZUxlaIhBwahyKArwMJy5uuPkbp49o8Lz2xSyJ2icQOYG2gcNn_J3flI1cDWJ8Oo4RT2ELVtrnv5qA8iTgOYKljyHQrhIs5XWQIQD5j1XQCVc9-PlJPrnwV7UzkUZYnAXwbmPrktf75BSv__4Iv8G50enRYHu4fH6zCLK3yWX_ZGsy0t_f2E1ovrf7sRfQPC47vcg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9UwFD5RDMYXoyA4RS0JCb7Mu61buz0Zot5c5EcIkXD1ZWm7NtwENoSRyH_vOd12ASG-7KVtup1z1p6v5-s5ABvapCKJXBEWCR3d8DgNdczxkVjcMKRUsqALznv7YnKUfp9m057_dNnTKoc10S_UVWPojHyEYFuitaG3PHI9LeLg6_jz-e-QKkhRpLUvp_EYnkhEKWThcirn5y0RAnfc3oe8jTwfGSLsELlLfkp9hspb-9I9Z_M-Z_KfwKnfj8Yv4HnvSLKtTvMv4ZGtl2CxKy15vQzH2zUuPD4ZeMsax85mh2GaxWxWMwTY5DSitlnbMMTMlKf7jz1l-hrbfGl6nJH9PJ5s_aL-mnjrLTM04uIVHI2__fgyCfsiCqHJkrRFoTtTcJPLxImqqrSJXFKIzLlUqtzZiKtCWKUjYWJulUT84rRRNuGIbFQUV3wFFuqmtq-BKfS1Km0VOgkq5ZXMqRiVsRWiIoeOoghgcxBhed7lyih9jJvnpRd2ScIuUdgBrA0SLvt_5rK80XAA6_NmtHYKYajaNlddH7QtEccBrHYKmU-F0DGnSw0ByDuqmnegTNp3W-rZic-onYk8yvIkgI-DUm-91oNf8Ob_X_ABnqJ1lrvb-ztv4RkN8gTAbA0W2osr-w4dmVa_9xb6FytU87A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+miR-451+in+resistance+to+paclitaxel+by+regulating+YWHAZ+in+breast+cancer&rft.jtitle=Cell+death+%26+disease&rft.au=Wang%2C+Wenrui&rft.au=Zhang%2C+Lingyu&rft.au=Wang%2C+Yangyang&rft.au=Ding%2C+Yongxing&rft.date=2017-10-05&rft.eissn=2041-4889&rft.volume=8&rft.issue=10&rft.spage=e3071&rft_id=info:doi/10.1038%2Fcddis.2017.460&rft_id=info%3Apmid%2F28981108&rft.externalDocID=28981108
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon